Buy Teriparatide 750mcg: Recombinant PTH 1-34 for Bone Metabolism Research

Teriparatide 750mcg is a synthetic recombinant form of human parathyroid hormone fragment (PTH 1-34), widely used in laboratory research to investigate bone formation, osteoblast activity, and bone density enhancement. This anabolic peptide stimulates osteoblast proliferation and differentiation, promoting new bone matrix deposition and supporting studies on osteoporosis models, fracture healing, bone remodeling mechanisms, and metabolic bone disorders in experimental settings.

Molecular Formula: C181H291N55O51S2 Molecular Weight: 4117.72 g/mol Purity: ≥99% (lyophilized, research-grade)

Important Notice: This peptide is strictly intended for research and laboratory use only. Not for human consumption, diagnostic, therapeutic, or veterinary purposes. Please review and agree to our Terms and Conditions before ordering.

What is Teriparatide?

Teriparatide is the N-terminal 1-34 fragment of human parathyroid hormone (PTH 1-34), produced recombinantly to mimic the bioactive portion of endogenous PTH. Unlike continuous PTH exposure (which promotes resorption), intermittent administration in research models favors anabolic effects on bone.

In preclinical and in-vitro studies, teriparatide activates the PTH/PTHrP receptor (PTH1R) on osteoblasts, leading to increased bone formation markers (e.g., procollagen type I N-terminal propeptide), enhanced trabecular and cortical bone architecture, and improved biomechanical strength.

The 750mcg vial (commonly corresponding to multi-dose or bulk formats in research) supports flexible reconstitution for dose-response experiments, chronic exposure models, or comparative studies.

Mechanism of Action in Research

Teriparatide is explored for:

• Stimulating osteoblast activity and bone formation via cAMP/PKA signaling
• Promoting modeling-based bone formation on quiescent surfaces
• Enhancing bone mineral density (BMD) at spine, hip, and other sites
• Increasing markers of bone turnover while favoring formation over resorption
• Supporting fracture callus formation and healing in injury models

These properties make teriparatide a key tool for studying anabolic pathways in bone without direct reliance on full-length PTH.

Key Research Findings and Applications

Teriparatide is a cornerstone in bone biology and osteoporosis research.

Bone Density and Osteoporosis Models

Studies demonstrate significant increases in lumbar spine and femoral neck BMD, with improvements in trabecular microarchitecture and reduced fracture risk analogs in preclinical systems.

Fracture Healing and Callus Formation

Research examines accelerated healing, enhanced callus strength, and reduced delayed/non-union in fracture models.

Bone Remodeling and Anabolic Effects

Investigations highlight modeling-based formation, increased osteoblast number/function, and sustained BMD gains when followed by antiresorptive agents in long-term models.

Broader Metabolic Bone Studies

Additional applications include models of glucocorticoid-induced osteoporosis, hypogonadal bone loss, and comparative anabolic vs. antiresorptive therapies.

Research Applications

The 750mcg format supports:

• In-vitro osteoblast/osteocyte cultures and bone formation assays
• Preclinical osteoporosis, fracture, and bone defect models
• BMD, histomorphometry, and biomechanical strength evaluations
• Dose-escalation, pharmacokinetics, and combination therapy experiments

Reconstitution typically uses bacteriostatic water or saline for precise concentrations in lab protocols (common research dosing analogs: 20–80 mcg/kg equivalents).

Why Choose 99% Pure Teriparatide 750mcg?

Our teriparatide provides ≥99% purity for reliable, reproducible results in receptor activation, bone turnover markers, and density endpoint studies. Third-party tested and lyophilized for stability.

In summary, Teriparatide 750mcg is a premium recombinant PTH 1-34 peptide for advanced research into bone formation, osteoporosis models, bone density enhancement, fracture healing, and anabolic bone metabolism. Advance your skeletal and regenerative investigations with this targeted research tool.

Latest Testing: Link to Report